Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 780.00 | 795.50 | 0.9805 | 0.9703 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 893.00 | 795.50 | 1.1226 | 1.1840 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 731.00 | 795.50 | 0.9189 | 0.8753 |
| BT-20 | Lapatinib | 10 | uM | 9 | 625.00 | 320.09 | 350.00 | 795.50 | 0.4400 | 0.0704 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 842.00 | 795.50 | 1.0585 | 1.0884 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 320.09 | 909.00 | 795.50 | 1.1427 | 1.2138 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 978.00 | 795.50 | 1.2294 | 1.3406 |
| BT-20 | Lapatinib | 1 | uM | 9 | 625.00 | 320.09 | 891.00 | 795.50 | 1.1201 | 1.1803 |
| BT-20 | Linsitinib | 10 | uM | 9 | 625.00 | 320.09 | 747.00 | 795.50 | 0.9390 | 0.9065 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 784.00 | 795.50 | 0.9855 | 0.9780 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 605.00 | 795.50 | 0.7605 | 0.6237 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 935.00 | 795.50 | 1.1754 | 1.2618 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 876.00 | 795.50 | 1.1012 | 1.1523 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 625.00 | 320.09 | 436.00 | 795.50 | 0.5481 | 0.2653 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 629.00 | 795.50 | 0.7907 | 0.6725 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 756.00 | 795.50 | 0.9504 | 0.9239 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 952.00 | 795.50 | 1.1967 | 1.2931 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 320.09 | 722.00 | 795.50 | 0.9076 | 0.8577 |
| BT-20 | Linsitinib | 1 | uM | 9 | 625.00 | 320.09 | 752.00 | 795.50 | 0.9453 | 0.9162 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 670.00 | 795.50 | 0.8422 | 0.7549 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 664.00 | 795.50 | 0.8347 | 0.7429 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 346.00 | 795.50 | 0.4350 | 0.0611 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 627.00 | 795.50 | 0.7882 | 0.6685 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 791.00 | 795.50 | 0.9943 | 0.9914 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 915.00 | 795.50 | 1.1502 | 1.2249 |